Navigation Links
First come, first served?
Date:12/30/2010

Emergency department overcrowding can result in long waiting times for seriously ill patients. They then compete with patients with less severe illnesses for the next available treatment. In this edition of Deutsches rzteblatt International (Dtsch Arztebl Int 2010; 107[50]: 892𔃆), Michael Christ and his coauthors provide an overview of current practice for initial assessment of emergency patients.

Triage provides reliable methods that can be used to assess the severity of an illness and the urgency of treatment in emergency departments.

In English-speaking countries, five-level triage systems are already being successfully applied. For example, trained nursing staff uses them to ascertain whether basic life support is needed, whether patients are in severe pain, or whether further diagnostic procedures are needed. Triage can significantly improve the mostly subjective assessment methods used in Germany. In Australia it is already improving patient safety, reducing their waiting times, and increasing the professional satisfaction of emergency department staff.

The authors' own experience shows that trained, specialized staff can use a German translation of the Emergency Severity Index to assess emergency patients in Germany reliably, too.


'/>"/>

Contact: Dr. Michael Christ
michael.christ@klinikum-nuernberg.de
Deutsches Aerzteblatt International
Source:Eurekalert

Page: 1

Related biology news :

1. Longevinex exhibits L-shaped safety curve for first time in resveratrol biology
2. Experts converge at Arizona State University for first preventive cancer vaccine conference
3. Hoyos Corporation Rolls Out First Iris-Biometrics System Priced to Compete with Generic Card Readers
4. Metabolism models may explain why Alzheimers disease kills some neuron types first
5. Scientists announce discovery of first horned dinosaur from South Korea
6. Researchers describe first functioning lipidome of mouse macrophage
7. Genome 10K Project announces first 101 species for genome sequencing
8. First-ever covalent irreversible inhibition of a protease central to hepatitis C infection
9. New guidance issued for first responders collecting suspected biothreat agents
10. First volume of new laboratory manual series on imaging is released
11. LSUHSC reports first successful salivary stone removal with robotics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/13/2016)... 2016  IMPOWER physicians supporting Medicaid patients in ... clinical standard in telehealth thanks to a new partnership ... platform, IMPOWER patients can routinely track key health measurements, ... index, and, when they opt in, share them with ... a local retail location at no cost. By leveraging ...
(Date:3/29/2016)... 2016 LegacyXChange, Inc. (OTC: ... SelectaDNA/CSI Protect are pleased to announce our successful effort ... variety of writing instruments, ensuring athletes signatures against counterfeiting ... from athletes on LegacyXChange will be assured of ongoing ... Bill Bollander , CEO states, "By ...
(Date:3/22/2016)... PROVO and SANDY, Utah ... Ontario (NSO), which operates the highest sample volume laboratory ... and Tute Genomics and UNIConnect, leaders in clinical sequencing ... announced the launch of a project to establish the ... panel. NSO has been contracted by ...
Breaking Biology News(10 mins):
(Date:6/27/2016)...  Liquid Biotech USA , ... Sponsored Research Agreement with The University of Pennsylvania ... cancer patients.  The funding will be used to ... clinical outcomes in cancer patients undergoing a variety ... employed to support the design of a therapeutic, ...
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial spectrophotometers and fluorometers ... the 6000i models are higher end machines that use the more unconventional z-dimension of ... beam from the bottom of the cuvette holder. , FireflySci has developed several ...
(Date:6/23/2016)... 23, 2016   Boston Biomedical , an ... designed to target cancer stemness pathways, announced that ... Orphan Drug Designation from the U.S. Food and ... cancer, including gastroesophageal junction (GEJ) cancer. Napabucasin is ... inhibit cancer stemness pathways by targeting STAT3, and ...
(Date:6/23/2016)... ... 2016 , ... Charm Sciences, Inc. is pleased to announce ... Research Institute approval 061601. , “This is another AOAC-RI approval of the Peel ... President of Regulatory and Industrial Affairs. “The Peel Plate methods perform comparably to ...
Breaking Biology Technology: